Galapagos « Terug naar discussie overzicht

Overname van....Gilead....?

3 Posts

Omlaag ↓

diederique 22 september 2016 21:19

kan zomaar gebeuren...

.....The latest idea? That the Dublin drugmaker may target Gilead, whose $107 billion market cap is quite a ways off
of the heights it reached last year.

www.fiercepharma.com/pharma/allergan-...

diederique 23 september 2016 00:25

Will Gilead Make a Good Fit for Allergan?

Allergen’s surprise interest emerged without any earlier indications of interest in companies focused on NASH or liver diseases. Given the backdrop of recent acquisitions, the market is abuzz with rumors about Gilead being the next potential target for Allergan.

www.investopedia.com/news/will-gilead...

diederique 23 september 2016 21:54

Allergan joins a growing field of companies intent on conquering NASH, which include Gilead Sciences Inc. GILD, -0.10% , Bristol-Myers Squibb Co. BMY, +0.23% , Intercept Pharmaceuticals Inc. ICPT, -2.42% , Galmed Pharmaecuticals Ltd. GLMD, -1.64% , Astra-Zeneca Plc AZN, -0.88% and Novartis AG NVS, -0.53% , among others, according to BioMedTracker.

www.marketwatch.com/story/allergan-is...

3 Posts

Aantal posts per pagina: 20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Detail

Vertraagd	11 apr 2025 17:35
Koers	21,160
Verschil	+0,060 (+0,28%)
Hoog	21,460
Laag	20,820
Volume	102.034
Volume gemiddeld	108.088
Volume gisteren	108.038

Galapagos nieuws

09 apr	Farmaceuten in het vizier van Trump	2
24 mrt	Video: omvangrijke investeringen in d...
19 feb	Deutsche Bank verlaagt koersdoel Gala...
18 feb	Tang Capital meldt flink belang in Ga...	1
13 feb	KBC Securities verlaagt koersdoel Gal...
13 feb	AEX houdt dapper stand op Super Thurs...	3
12 feb	Cashburn en kaspositie Galapagos vrij...
12 feb	Beursblik: focus op opsplitsingplan b...
10 feb	Deze bedrijven kunnen deze week voor ...
23 jan	Barclays zet Galapagos op de verkoopl...

Meer ››